-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IsXon+HVwHn7zvbq/65QuIchnohowNsBKQhqoob1muU6clXl1Us1s9h1RzM5gJQQ X0WFA2ePpEbnXRHv4yeQIQ== 0001257957-05-000012.txt : 20050224 0001257957-05-000012.hdr.sgml : 20050224 20050224084530 ACCESSION NUMBER: 0001257957-05-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050222 FILED AS OF DATE: 20050224 DATE AS OF CHANGE: 20050224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OHANLEY PETER D CENTRAL INDEX KEY: 0001285527 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 05635823 BUSINESS ADDRESS: STREET 1: 6134 NE ALMEDA ST CITY: PORTLAND STATE: OR ZIP: 97213 BUSINESS PHONE: 5032881100 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-02-22 0 0000873303 AVI BIOPHARMA INC AVII 0001285527 OHANLEY PETER D 6134 NE ALAMEDA STREET PORTLAND OR 97213 0 1 0 0 Sr. Vice President Incentive Stock Option (right to buy) 2.53 2005-02-22 4 A 0 32904 0 A 2006-02-22 2015-02-22 Common Stock 32904 32904 D Incentive Stock Option (right to buy) 2.89 2004-03-29 4 A 0 100000 0 A 2005-03-29 2014-03-29 Common Stock 100000 100000 D Non-Qualified Stock Option (right to buy) 2.53 2005-02-22 4 A 0 17096 0 A 2006-02-22 2015-02-22 Common Stock 17096 17096 D The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date. Vesting: 25% of the shares vest each year from the date of grant with all shares vesting in four years. By: Mark M. Webber, Attorney-in-fact For: Peter D. O'Hanley 2005-02-23 -----END PRIVACY-ENHANCED MESSAGE-----